Vaccine Design and Testing – News and Features

Researchers have identified three gene variants in the DNA of 486 HIV infected people that appear to have helped some of the patients fight off the virus and delay the onset of full-blown AIDS.

The award supports advanced preclinical studies and manufacturing process development for new adjuvant technologies based on Alphavax’s vector platform.

The Company will make multiple presentations regarding its electroporation-mediated DNA delivery technology at the meeting.

Nastech to evaluate Carrington's GelSite for potential to enhance intranasal delivery of Nastech's peptide and protein therapeutics in liquid formulations.

Researchers involved in the Influenza Genome Sequencing Project have sequenced the genomes of more than 2,000 influenza viruses.

Panacea Biotec is to in-license CBL’s stable liquid technology to develop, produce and market a liquid version of pentavalent.

OGT has been selected to design and fabricate microarrays for the Innate Discovery Team as part of the Centre for HIV-AIDS Vaccine Immunology research project to develop vaccines for HIV.

Bellicum announces licensing agreement with Ariad for development of new cancer therapies.

Bill & Melinda Gates Foundation supports series with grant of $2.5 million.

The site includes updated information about developments in HIV medication and other infectious disease issues.